Global Cold and Flu Drugs Market Size by Type, by Application, by Geographic Scope And Forecast

Cold and Flu Drugs Market Size And Forecast

Cold and Flu Drugs Market was valued at USD 13.16 Billion in 2019 and is projected to reach USD 24.55 Billion by 2027, growing at a CAGR of 8.06% from 2020 to 2027.

Global Cold and Flu Drugs Market Overview

Increasing prevalence of digestion disorders, as well as increasing cases of obesity all over the globe, increasing binge eating and consumption of junk foods are driving growth of the market. According to American Nutrition Association, 2016, around 70 million people suffer from some form of digestion disorder such as indigestion, acid reflux, irritable bowel syndrome, and constipation daily. Patients suffering from these conditions are reported to use non-prescription medicines. OTC drugs widely used to treat symptoms of cold and flu worldwide. Increasing prevalence of viral infections causing cold and flu is creating a favorable environment for growth of Cold and Flu Drugs market.

Global Cold and Flu Drugs Market: Segmentation Analysis

The Global Cold and Flu Drugs Market is segmented based on Type, Application, and Geography.

Key Players in Cold and Flu Drugs Market

The Global Cold and Flu Drugs Market study report will provide a valuable insight with an emphasis on the global market. The major players in the market are Bayer, AstraZeneca, Procter and Gamble, Reckitt Benckiser Group, Johnson & Johnson, GlaxoSmithKline, Novartis, Sun Pharmaceutical Industries, Pfizer, and Prestige Brands Holdings.

1 Introduction of Global Cold and Flu Drugs Market

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 Executive Summary

3 Research Methodology

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 Global Cold and Flu Drugs Market Outlook

4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 Global Cold and Flu Drugs Market, by Type

5.1 Overview
5.2 Antihistamines
5.3 Expectorants
5.4 Bronchodilators
5.5 Decongestants
5.6 Other

6 Global Cold and Flu Drugs Market, by Application

6.1 Overview
6.2 Over the Counter (Otc)
6.3 Rx

7 Global Cold and Flu Drugs Market, by Geography

7.1 Overview
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 U.K.
7.3.3 France
7.3.4 Rest of Europe
7.4 Asia-Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Rest of Asia-Pacific
7.5 Rest of the World
7.5.1 Latin America
7.5.2 Middle East

8 Global Cold and Flu Drugs Market Competitive Landscape

8.1 Overview
8.2 Company Market Ranking
8.3 Key Development Strategies

9 Company Profiles

9.1 Bayer
9.1.1 Overview
9.1.2 Financial Performance
9.1.3 Product Outlook
9.1.4 Key Developments
9.2 Astrazeneca
9.2.1 Overview
9.2.2 Financial Performance
9.2.3 Product Outlook
9.2.4 Key Developments
9.3 Procter and Gamble
9.3.1 Overview
9.3.2 Financial Performance
9.3.3 Product Outlook
9.3.4 Key Developments
9.4 Reckitt Benckiser Group
9.4.1 Overview
9.4.2 Financial Performance
9.4.3 Product Outlook
9.4.4 Key Developments
9.5 Johnson &Amp; Johnson
9.5.1 Overview
9.5.2 Financial Performance
9.5.3 Product Outlook
9.5.4 Key Developments
9.6 GlaxoSmithKline
9.6.1 Overview
9.6.2 Financial Performance
9.6.3 Product Outlook
9.6.4 Key Developments
9.7 Novartis
9.7.1 Overview
9.7.2 Financial Performance
9.7.3 Product Outlook
9.7.4 Key Developments
9.8 Sun Pharmaceutical Industries
9.8.1 Overview
9.8.2 Financial Performance
9.8.3 Product Outlook
9.8.4 Key Developments
9.9 Pfizer
9.9.1 Overview
9.9.2 Financial Performance
9.9.3 Product Outlook
9.9.4 Key Developments
9.10 Prestige Brands Holdings
9.10.1 Overview
9.10.2 Financial Performance
9.10.3 Product Outlook
9.10.4 Key Developments

10 Appendix

10.1 Related Research